Home > Companies > Theranica
Last Update 29.8.2022Edit Profile
Theranica logo
Theranica
Neuromodulation-based Patch for Migraine Relief
Non Visible
 
http://theranica.com/

About

Theranica is the developer of Nerivio, a fully integrated, self-contained family of therapeutic patches. The patches and other types of wearables in the companys pipeline are controlled by smartphone applications to easily adapt therapy treatments to everyday life. Theranicas Nerivio Migra is a migraine-relief patch that provides migraine treatment through neuromodulation. Instead of placing electrodes on their head, patients can attach Theranicas clinically tested, wearable patch to their arm and launch a personalized pain-relief program. Theranica combines electrical neurostimulation and neuromuscular stimulation technologies with modern wireless communication and smartphone applications. The company uses these advanced technologies to design and deliver effective products for treating a variety of severe and common medical problems. In May 2019, Theranica won FDA De Novo clearance for its Nerivio Migra device. In June 2019, the company announced the establishment of a wholly owned subsidiary company, Theranica USA, headquartered in Montclair, New Jersey. Nerivio appeared on TIMEs List of 100 Best Inventions of 2019. Theranica was also listed as one of 36 game-changing companies in 2020 by New York-based research firm CB Insights.

Founded

11/2015

Business models

B2C, B2B2C

Employees

11-50

Product stage

Released

Products

Nerivio Migra

Geographic markets

Europe, China, United States

Funding

Total Funding

$88.1M

Last Funding

$45M

Funding Stage

C+

Total Rounds

5

Investors

10

News

  (32)
www.prnewswire.comAug 29, 2022
Theranica Secures $45 Million Series C Funding Round
www.prnewswire.comJun 1, 2022
Costco Wholesale Corporation Adds Nerivio® to Its Member Prescription Program
www.jpost.comOct 25, 2021
https://www.jpost.com/health-and-wellness/mind-and-spirit/us-study-shows-israeli-device-effective-against-chronic-migraines-683010
techtime.co.ilSep 2, 2021
אינפיניטי השקיעה 3.5 מיליון שקל בתרניקה - Techtime - חדשות אלקטרוניקה והייטק
www.prnewswire.comAug 16, 2021
Theranica Announces the Establishment of a Unique Level II HCPCS Code by the Centers for Medicare and Medicaid Services (CMS)
www.prnewswire.comJun 21, 2021
Peer-Reviewed Study Suggests Nerivio® Effective for Treatment of Acute Menstrual Migraine Headache
www.israel21c.orgMay 27, 2021
Migraine device wins 2021 MedTech Breakthrough Award
www.prnewswire.comMar 2, 2021
Nerivio® Drug-free Wearable Surpasses 100,000 Migraine Treatments in the US
www.mobihealthnews.comJan 25, 2021
Theranica's migraine DTx receives FDA clearance for adolescent use
www.prnewswire.comSep 17, 2020
Largescale Real-World Migraine Study Solidifies Efficacy And Safety of Theranica's Nerivio® Device
www.prnewswire.comSep 8, 2020
Nerivio® Smartphone-Controlled Wearable for Acute Treatment of Migraine Granted CE Mark for Use in Europe
www.prnewswire.comJul 15, 2020
Theranica Reports Positive Study Results of Nerivio® for Chronic Migraine Patients
www.prnewswire.comJun 1, 2020
Theranica Kicks Off Migraine & Headache Awareness Month Rebate Program for Nerivio®, Its FDA-Authorized Migraine Treatment Wearable
www.prnewswire.comMay 18, 2020
Theranica Expands Executive Team Amid Growing US Demand for Its FDA-authorized Migraine Treatment Wearable Device
www.prnewswire.comFeb 25, 2020
Theranica Expands Accessibility of Nerivio™ to U.S. Migraine Patients Via Partnership With Telemedicine Platform, Cove
nocamels.comJan 23, 2020
Migraine-Zapping Device Developed By Israeli Biomedical Firm Offers Hope For Sufferers
nocamels.comDec 19, 2019
Israeli Firm Theranica, Developer Of Migraine-Zapping Device, Hailed As 2020 'Game-Changer'
www.prnewswire.comDec 3, 2019
Theranica: Journal of Expert Review of Medical Devices Publishes Profile of Nerivio™
www.prnewswire.comNov 21, 2019
Theranica's Nerivio™ Named in TIME's List of 100 Best Inventions of 2019
www.prnewswire.comNov 18, 2019
Theranica Announces U.S. Recycling Partnership in Commitment to Sustainable Medical Device Production
investingnews.comAug 6, 2019
Theranica Bioelectronics Hopes to Take Migraine Device Global
www.mobilehealthtimes.comJul 24, 2019
New Study Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications
www.jpost.comJul 5, 2019
https://www.jpost.com/Opinion/Hillels-Tech-corner-Disrupting-the-migraine-business-594657
www.prnewswire.comJun 24, 2019
Theranica Appoints Senior Executives to Lead its New USA Subsidiary
www.prnewswire.comJun 23, 2019
Theranica: New Publication Compares Remote Electrical Neuromodulation for Acute Treatment of Migraine to Treatment with Acute Medications
www.medgadget.comMay 29, 2019
Nerivio Migra Wins FDA De Novo Clearance for Acute Treatment of Migraines
markets.businessinsider.comMay 13, 2019
OMRON VENTURES Joins Theranica's Series B Funding Round as Strategic Investor
en.globes.co.ilMar 18, 2019
Israeli migraine device co Theranica raises $35m
www.neurologylive.comNov 16, 2018
Brian Grosberg, MD: Nerivio Migra Device for Acute Migraine Treatment
www.prnewswire.comNov 15, 2018
Theranica Announces Results from Pivotal Study of Device for Treating Acute Migraine
www.prnewswire.comJul 3, 2017
Theranica Raises $6M to Combat Migraine
www.finsmes.comSep 21, 2016
Theranica Bio-Electronics Closes Seed Financing Round - FinSMEs

The Team

(5)
AI
Alon Ironi
Co-founder, President & CEO
Ronen Jashek
Co-Founder, COO
Slava Barabash
Co-founder, VP R&D
DH
Dagan Harris
VP Clinical and Regulatory Affairs
EP
Eran Porat
CFO

Company Lifecycle

Event View
Timeline View

Use Cases (0)

Media gallery

(2)
NERIVIO - New device for migraine relief logo
NERIVIO - New device for migraine relief
Theranica Introduction logo
Theranica Introduction

Locations

Israel

Ha-Omanut St 4, Netanya, Israel

Offices Abroad

151 Forest St, Montclair, NJ 07042, USA

Sector

Life Sciences & HealthTech
Digital Health
Digital Therapeutics

Core Technology

Semiconductors & Electronics
Wearables

Target Industry

Consumers
Demographics & Family
Women
Teenagers & Young Adults
Healthcare & Life Sciences
Healthcare
Patients

Tags

(16)
migraine acute-care mhealth digital-healthcare wearable non-invasive medical-devices mobile-platform pain-relief personalization neurology neuro-stimulation mobile-applications wellness digital-therapeutics women-health

Target Markets

(3)
patients women chronic-patients

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Data and visuals presented here may not be used without the written consent of Start-Up Nation Finder.
Copyright © 2022 Terms of Use Privacy Policy